Skip to main content
SpringerLink
Log in

Absence of FHIT expression is associated with apoptosis inhibition in colorectal cancer

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

The fragile histidine triad (FHIT) gene, a candidate tumor suppressor gene located at 3p14.2, has been shown to be involved in the carcinogenesis of many human tissues, including digestive tract tissues. However, the expression and the role of the FHIT in the initiation and the development of the colorectal cancer (CRC) are poorly understood. We have shown that the FHIT gene exhibits significantly decreased expression in human CRC compared to colorectal adenoma and normal colorectal tissue by tissue microarray (TMA). The positive rate of FHIT gene expression in normal colorectal tissue, adenoma and adenocarcinoma were 93.75%, 68.75% and 46.25%, respectively. We show this decreased expression to be significantly correlated with the progression of colorectal carcinoma (P<0.05) as well as with differentiation and lymph node metastasis (P<0.05). We detected two somatic alterations in the FHIT gene in human CRC. The presence of this mutation correlated significantly with decreased FHIT expression in the human CRC. In our present study we tested the hypothesis that the decreased FHIT expression resulted in apoptosis inhibition associated with abnormal expression of apoptosis related proteins. To test this hypothesis we did a series of experiments. In the first test, we assessed apoptosis status using a standard TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling) assay by comparing FHIT-positive CRC vs. FHIT-negative CRC. In the second experiment, the protein expression of the FHIT and other apoptosis related proteins (Bax, Bcl-2 and Survivin) were measured in human CRC by TMA. Our combined results demonstrate the mutation in the FHIT gene significantly reduced FHIT expression in human CRC. Both TUNEL and TMA experiments demonstrated significantly inhibited apoptosis by down-regulation of Bax and the up-regulation of Survivin and Bcl-2. Collectively, these studies identify the mechanism by which an important tumor suppressor gene, FHIT is inactivated specifically in human CRC contributing to our understanding of the mechanism of colorectal carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ohta M, Inoue H, Cotticelli M G, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce C M, Huebner K. The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated T (3; 8) breakpoint, is abnormal in digestive tract cancers. Cell, 1996, 84(4): 587–597

    Article  CAS  PubMed  Google Scholar 

  2. Sozzi G, Veronese M L, Negrini M, Baffa R, Cotticelli M G, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti M A, Ohta M, Huebner K, Croce C M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 1996, 85(1): 17–26

    Article  CAS  PubMed  Google Scholar 

  3. Kastury K, Baffa R, Druck T, Ohta M, Cotticelli M G, Inoue H, Negrini M, Rugge M, Huang D, Croce C M, Palazzo J, Huebner K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res, 1996, 56(5): 978–983

    CAS  PubMed  Google Scholar 

  4. Boldog F, Gemmill R M, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov M R, Klinger H, Drabkin H A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet, 1997, 6(2): 193–203

    Article  CAS  PubMed  Google Scholar 

  5. Hayashi S, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K, Nakachi K. Abnormal FHIT transcripts in human breast carcinomas: A clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res, 1997, 57(10): 1981–1985

    CAS  PubMed  Google Scholar 

  6. Huebner K, Hadaczek P, Siprashvili Z, Druck T, Croce C M. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B. Biochim Biophys Acta, 1997, 1332(3): M65–M70

    CAS  PubMed  Google Scholar 

  7. Siprashvili Z, Sozzi G, Barnes L D, McCue P, Robinson A K, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti M A, Croce C M, Huebner K. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA, 1997, 94(25): 13771–13776

    Article  CAS  PubMed  Google Scholar 

  8. Wistuba I I, Behrens C, Virmani A K, Mele G, Milchgrub S, Girard L, Fondon J W 3rd, Garner H R, McKay B, Latif F, Lerman M I, Lam S, Gazdar A F, Minna J D. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res, 2000, 60(7): 1949–1960

    CAS  PubMed  Google Scholar 

  9. Sozzi G, Sard L, De Gregorio L, Marchetti A, Musso K, Buttitta F, Tornielli S, Pellegrini S, Veronese M L, Manenti G, Incarbone M, Chella A, Angeletti C A, Pastorino U, Huebner K, Bevilaqua G, Pilotti S, Croce C M, Pierotti M A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res, 1997, 57(11): 2121–2123

    CAS  PubMed  Google Scholar 

  10. Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce C M. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res, 1999, 59(16): 3866–3869

    CAS  PubMed  Google Scholar 

  11. Pavelic K, Krizanac S, Cacev T, Hadzija M P, Radosevic S, Crnic I, Levanat S, Kapitanovic S. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosisclinical evidence in lung and head and neck carcinomas. Mol Med, 2001, 7(7): 442–453

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K, Takagi H. Alternative splicing of the FHIT gene in colorectal cancers. Jpn J Cancer Res, 1997, 88(4): 385–388

    Article  CAS  PubMed  Google Scholar 

  13. Luceri C, Guglielmi F, De Filippo C, Caderni G, Mini E, Biggeri A, Napoli C, Tonelli F, Cianchi F, Dolara P. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas. Scand J Gastroenterol, 2000, 35(6): 637–641

    Article  CAS  PubMed  Google Scholar 

  14. Hao X P, Willis J E, Pretlow T G, Rao J S, MacLennan G T, Talbot I C, Pretlow T P. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res, 2000, 60(1): 18–21

    CAS  PubMed  Google Scholar 

  15. Thiagalingam S, Lisitsyn N A, Hamaguchi M, Wigler M H, Willson J K, Markowitz S D, Leach F S, Kinzler K W, Vogelstein B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res, 1996, 56(13): 2936–2939

    CAS  PubMed  Google Scholar 

  16. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi O P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4(7): 844–847

    Article  CAS  PubMed  Google Scholar 

  17. Knosel T, Emde A, Schluns K, Chen Y, Jurchott K, Krause M, Dietel M, Petersen I. Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia, 2005, 7(8): 741–747

    Article  PubMed Central  PubMed  Google Scholar 

  18. Cao J, Li W L, Du H, Tang W B, Wang H. FHIT and p53 expression in human colonic carcinoma. Chin J Exp Surg, 2006, 23(7): 787–789

    CAS  Google Scholar 

  19. Vaux D L, Korsmeyer S J. Cell death in development. Cell, 1999, 96(2): 245–254

    Article  CAS  PubMed  Google Scholar 

  20. Druck T, Hadaczek P, Fu T B, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese M L, Rosen D, Rothstein J, McCue P, Cotticelli M G, Inoue H, Croce C M, Huebner K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res, 1997, 57(3): 504–512

    CAS  PubMed  Google Scholar 

  21. Virgilio L, Shuster M, Gollin S M, Veronese M L, Ohta M, Huebner K, Croce C M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA, 1996, 93(18): 9770–9775

    Article  CAS  PubMed  Google Scholar 

  22. Yang E, Zha J, Jockel J, Boise L H, Thompson C B, Korsmeyer S J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2 displaces Bax and promotes cell death. Cell, 1995, 80(2): 285–291

    Article  CAS  PubMed  Google Scholar 

  23. Reed J C. Bcl-2 and the regulation of programmed cell death. J Cell Biol, 1994, 124(1–2): 1–6

    Article  CAS  PubMed  Google Scholar 

  24. Altieri D C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 2003, 22(53): 8581–8589

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou, 510180, China

    Cao Jie MD, Li Wanglin, Xia Jie, Tang Weibiao, Wang Hui, Chen Xiwen & Xiao Huanqing

  2. Center of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Chen Xiaoping MD

  3. Department of Pathology, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou, 510180, China

    Du Hong

  4. Department of Scientific Research and Education, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou, 510180, China

    Chen Shanming

  5. Department of Gastroenterology, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou, 510180, China

    Li Yuyuan MD

Authors
  1. Cao Jie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Xiaoping MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li Wanglin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xia Jie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Du Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tang Weibiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chen Shanming
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wang Hui
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chen Xiwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiao Huanqing
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Li Yuyuan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cao Jie MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, J., Chen, X., Li, W. et al. Absence of FHIT expression is associated with apoptosis inhibition in colorectal cancer. Front. Med. China 1, 147–156 (2007). https://doi.org/10.1007/s11684-007-0028-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-007-0028-0

Keywords

Search

Navigation